Pharmacokinetics and antiviral activity of PHX1766, a novel hepatitis C virus protease inhibitor using an accelerated Phase 1 study design
暂无分享,去创建一个
Richard | H. Janssen | J. Schinkel | C. Weegink | Molenkamp | R. D. Knegt | Teresa | H. Guler | D. Hotho | J. Bruijne | Marie O’Farrell | Boyea | R. J. Knegt